LASITA M50

LASITA M50

Composition

Sitagliptin 50mg & Metformin Prolonged Release 500mg Tablets

Pack: 10 tablets/strip

DOSAGE: ONCE DAILY

SITAGLIPTIN:

  • It is an oral, potent and selective Dipeptidyl peptidase-4 (DPP-4) inhibitor.
  • Provides effective glucose lowering and well-tolerated in patients with type 2 diabetes.

METFORMIN:

  • Promotes weight loss in patient with obesity with non insulin dependent diabetes mellitus.
  • Suppresses hepatic gluconeogenesis.

Drugs of today

The combination of sitagliptin with metformin allows a broad and complementary spectrum of antidiabetic actions. This combination does not increase the risk of hypoglycaemia nor does it promote weight gain